Insider trade

Bio-Rad Laboratories (BIO): Officer sold ~$136K

Eva Anette Engelhardt, Officer at Bio-Rad Laboratories, sold ~$136K of Bio-Rad Laboratories shares.

~$136K
Approx. value · 550 sh @ $246.54
346
Holds after · shares reported
Traded
May 11, 2026
Filed
May 13, 2026

What stands out in this filing

  • The sale was 61.4% of the shares this insider held before it; the filing reports 346 shares afterwards.
  • 550 shares at an average of $246.54 each, as reported on the form.
  • No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Apr 21, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On April 21, 2026, at the annual meeting of stockholders (the “Annual Meeting”) of Bio-Rad Laboratories, Inc. (the “Company”), as further described in Item 5.07 below, the Company’s stockholders approved the Amended Bio-Rad Laboratories, Inc. 2017 Incentive Award Plan (the “Plan”).”
  2. Apr 30, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  3. May 11, 2026 · this disclosureInsiderOfficer sold ~$136K of BIO shares in the open market

What came next

  1. Jul 31, 2026Company filing · Form 8-K · Results, RestructuringAnnounced job cuts, closures or a restructuring, and reported its results (and 1 more item)“On July 31, 2026, Bio-Rad Laboratories, Inc. (the “ Company ") initiated a strategy-driven restructuring plan as part of our ongoing program to improve operating performance and strengthen the Company’s competitive position.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Bio-Rad Laboratories

For Bio-Rad Laboratories, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BIO page.

How this filing works

Explore the data

Common questions

Which Bio-Rad Laboratories (BIO) insider traded, and how much?

Eva Anette Engelhardt, Officer at Bio-Rad Laboratories, sold ~$136K of Bio-Rad Laboratories shares. 550 shares at $246.54.

When did it happen, and when was it made public?

Traded: May 11, 2026. Filed: May 13, 2026. That is 2 days between the two dates.

What stands out in this filing?

The sale was 61.4% of the shares this insider held before it; the filing reports 346 shares afterwards. 550 shares at an average of $246.54 each, as reported on the form. No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Bio-Rad Laboratories recently?

For Bio-Rad Laboratories, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BIO page.

Does this mean BIO stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Bio-Rad Laboratories

Everything OQRO holds on this company is on its BIO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data